Therapy Physics Boards Field Guide
Physics-only rapid review for radiation oncology trainees who have already learned the material and now need fast retrieval under board conditions. Biology is intentionally out of scope.
Legend
A = λN equation or calculation trigger
0.511 MeV number worth memorizing
TG-51 protocol, report, or standard
linac hardware or clinical delivery detail
bold red common board-style trap
Purpose
This is not a textbook. It is a retrieval map: equations, units, assumptions, and the small distinctions that turn a familiar topic into a board question. The writing is intentionally concise and conversational, with mutable protocol and regulatory details checked against public AAPM, NRC, NIST, eCFR, and ICRU reference pages.
Graduating Resident Target
Use this as a cram sheet after first learning the physics. It is optimized for "recognize the question type, choose the governing equation or protocol, avoid the trap, calculate if needed." The densest sections are calculation templates, machine/component logic, QA/protocol tolerances, and brachy/protection rules.
E = hf = hc / λ
Use hc = 1240 eV nm.
A = λN
Activity is disintegrations per second.
T1/2 = 0.693 / λ
Mean life = 1 / λ = 1.44 T1/2.
A(t) = A0e-λt = A0(1/2)n
n = t / T1/2.
I = I0e-μx
HVL = 0.693 / μ; TVL = 2.303 / μ.
Inverse square = (dold / dnew)2
Short SSD makes this unforgiving.
Equivalent square = 4A / P
Use for rectangular field scatter lookup.
DwQ = M kQ ND,w60Co
Core TG-51 relation.
dref,e = 0.6R50 - 0.1 cm
Electron reference depth.
R50 ≈ E0 / 2.33
Electron mean incident energy.
B = P d2 / (WUT)
Primary barrier transmission.
TG-43: Ddot = SKΛGgF / G0
Geometry, radial dose, anisotropy.
BED = nd[1 + d/(α/β)]
Fractionation comparison.
EQD2 = BED / [1 + 2/(α/β)]
Convert to 2 Gy/fx equivalent.
Calculation Playbook
Units, Decay, and Fractionation
| Question Type | Template | Speed Check |
| Frequency to wavelength |
Convert prefix first, then λ = c/f. |
3000 MHz = 3 x 109 Hz gives 0.1 m. |
| Photon energy |
E = hf = hc/λ. For wavelength in nm, use 1240 eV nm. |
Energy increases as wavelength decreases. |
| Activity from atoms |
Convert half-life to seconds, compute λ = 0.693/T1/2, then A = λN. |
If T1/2 = 6.93 x 103 s and N = 104, activity = 1 Bq. |
| Elapsed half-lives |
fraction remaining = (1/2)t/T1/2. |
1, 2, 3, 4 half-lives = 50%, 25%, 12.5%, 6.25%. |
| Mean life |
τ = 1/λ = 1.44T1/2. |
At one mean life, activity is 36.8% of initial. |
| Effective half-life |
Teff = TphysTbio/(Tphys + Tbio). |
Always shorter than both physical and biologic half-life. |
| Fractionation comparison |
BED = nd[1 + d/(α/β)], then EQD2 = BED/[1 + 2/(α/β)]. |
Late-effect tissues use low α/β values; higher dose per fraction matters more. |
| Nuclear reaction balancing |
Conserve total A and total Z on both sides. |
Do A first, then Z. It prevents isotope-choice guessing. |
Beam Geometry and Monitor Units
| Question Type | Template | Fast Trap Check |
| SSD/PDD MU |
MU = Rx / [O ScSpWF TF OAR (PDD/100) ISF]. |
PDD table means SSD geometry. Use field size at patient for Sp. |
| SAD/TMR MU |
MU = Rx / [O ScSpWF TF OAR TMR]. |
Parallel-opposed equally weighted beams: divide Rx by 2 before MU per beam. |
| Depth-dose transfer |
If MU/geometry is unchanged, dose ratio between depths equals PDD or TMR ratio at those depths. |
For same SSD beam, D3/D6 = PDD3/PDD6. |
| Equivalent square |
eq square = 4A/P = 2ab/(a+b) for rectangle. |
Use collimator equivalent square for Sc; blocked/MLC field for Sp. |
| Wedge angle |
θwedge = 90 - hinge/2. |
Hinge 135 degrees -> 22.5 degree wedge. |
| Gap for matching fields |
gap = d(L1/SSD1 + L2/SSD2)/2. |
Use half-field length from central axis to match line. Half-beam block has no divergence on blocked side. |
| Radiologic depth |
drad = Σ ρrelt. |
Low-density lung reduces water-equivalent depth; bone increases it. |
Shielding and Source Timing
| Question Type | Template | Fast Trap Check |
| HVL/TVL | HVL = 0.693/μ; TVL = 2.303/μ; n = log10(I0/I). | Each TVL reduces intensity by 10x, not by 90% of original repeatedly in linear units. |
| Primary barrier | B = Pd2/(WUT). | Uncontrolled area design goal is much lower than controlled area. |
| IMRT leakage workload | WL = C W, commonly C = 2-10. | More MU means more leakage workload. |
| HDR decay correction | tnow = tnominalSnominal/Snow. | If the source has decayed, treatment time gets longer. |
| Permanent implant total dose | Total dose is proportional to initial dose rate x mean life, D ∝ R0/λ. | Shorter half-life needs higher initial dose rate for same total dose. |
| Transit dose | More source travel events -> more transit contribution. | For same total dose, more HDR fractions usually means more transit dose. |
Most questions are not asking for a fact in isolation. They tie two pieces of information together: a unit plus its base dimension, a machine component plus what changes in electron mode, a formula plus the condition under which it is valid, or a protocol plus what it does not cover.
Default board behavior: identify the quantity, check units, check geometry, check energy range, then ask whether the word "EXCEPT" flipped the task. If the question contains a table, decide first whether it is an SSD/PDD problem or an SAD/TMR problem.
| Question Style | Fast Response | Common Trap |
| Derived SI unit | Gy, Sv, J, N, Bq are derived; kg is base. | Confusing named SI units with base SI units. |
| Changes with filtration | HVL and effective energy increase; intensity decreases; max energy unchanged. | Thinking filtration increases kVp. |
| Electron mode on linac | Target out, flattening filter out, scattering foil or scanning in, applicator in, monitor chamber still used. | Removing the monitor chamber. |
| Short SSD superficial x-rays | Inverse square sensitivity is huge. | Blaming air attenuation first. |
| Orthovoltage vs MV | Bone dose rises with kV because photoelectric effect is Z-sensitive. | Applying MV Compton logic to kV beams. |
Trap Decoder Library
| If The Question Mentions... | Think First | Likely Answer Direction |
| "EXCEPT" | Underline the negation. | The right answer is the non-member, not the most familiar true statement. |
| SI units | Base vs derived. | kg, m, s, A, K, mol, cd are base; Gy/Sv/J/N/Bq are derived. |
| Inelastic collision | Conserved quantity. | Momentum conserved; kinetic energy not necessarily conserved. |
| Cyclotron energy limit | Relativistic mass/phase mismatch. | At high velocity, particle no longer stays synchronized with fixed RF. |
| Filtered kV beam | Beam hardening. | HVL/effective energy up, intensity down, max energy unchanged. |
| Gamma Knife in brain | Co-60 energy in soft tissue. | Compton dominates. |
| 18 MV photons | Photonuclear threshold. | Neutron dose is a concern. |
| SF6 in waveguide | Insulation/dielectric strength. | Do not choose cooling or acceleration. |
| TLD vs OSLD | Readout stimulus. | TLD = heat; OSLD = light. |
| Rounded MLC leaf end | Consistent penumbra plus dosimetric leaf gap. | Do not confuse DLG with physical leaf gap alone. |
| Annual SRS/SBRT end-to-end | Measured vs calculated dose tolerance. | Think 5% for end-to-end dosimetric agreement. |
| Patient release after implant/unsealed source | Public exposure from released patient. | Release if another individual unlikely to exceed 5 mSv TEDE. |
| Proton range question | HU-to-stopping-power and beam-direction uncertainty. | Range margin is not a uniform isotropic PTV expansion. |
| DICOM object list | RTPLAN/RTSTRUCT/RTDOSE/RTIMAGE/REG/waveforms. | Machine log file is the non-DICOM-style answer. |
Unit Sense and Constants
| Quantity | Board Value | Use |
| Speed of light | 3.00 x 108 m/s | c = fλ |
| Planck relation | E = hf = hc/λ | hc = 1240 eV nm |
| Electron rest energy | 0.511 MeV | Pair production threshold = 1.022 MeV. |
| Proton/electron mass ratio | 1836 | Proton is about 1800 times electron mass. |
| Atomic mass unit | 931.5 MeV/c2 | Mass defect to binding energy. |
| Avogadro | 6.022 x 1023 mol-1 | Atoms per mole. |
| Curie | 3.7 x 1010 Bq | Old activity unit. |
| Roentgen | 2.58 x 10-4 C/kg air | Exposure for photons in air; 1 R ~ 0.876 cGy in air. |
| Gray | 1 J/kg | Absorbed dose. |
| Sievert | Gy x weighting factors | Protection quantity, not tumor prescription dose. |
Base vs Derived SI Units
| Base SI | Derived / Named SI | Physics Board Translation |
| meter (m), kilogram (kg), second (s) | newton, joule, gray | N = kg m s-2; J = N m; Gy = J kg-1. |
| ampere (A), kelvin (K), mole (mol), candela (cd) | coulomb, volt, becquerel, sievert | Bq = s-1; Sv = J kg-1 after weighting factors. |
Mechanics and Accelerator One-Liners
- Inelastic collision: momentum is conserved; kinetic energy is not. If the bodies stick together, it is perfectly inelastic.
- Work-energy: W = Fd cosθ and KE = 1/2 mv2 for nonrelativistic particles.
- Relativistic energy: E2 = (pc)2 + (m0c2)2; for photons, E = pc.
- Cyclotron limit: fixed-frequency cyclotrons lose synchrony at relativistic speeds because effective mass increases; synchrocyclotrons vary RF frequency to compensate.
- Synchrotron: magnetic field and RF frequency are varied so particles stay in a fixed orbit while energy increases.
Atomic and Nuclear Bookkeeping
- Atomic number Z is protons; mass number A is nucleons; neutrons = A - Z.
- Isotopes share protons, isobars share A, isotones share neutrons. Memory: P-A-N.
- Shell capacity = 2n2. K shell has 2, L has 8, M has 18.
- Characteristic x-rays occur when an outer-shell electron fills an inner-shell vacancy. Auger electrons are the competing non-radiative route.
- Binding energy per nucleon peaks near iron. Fission of heavy nuclei and fusion of light nuclei both move toward higher binding energy per nucleon.
Board check: A photon has frequency 3000 MHz. What is the wavelength?
Convert first: 3000 MHz = 3 x 109 Hz. Then λ = c/f = 3 x 108 / 3 x 109 = 0.1 m. The trap is failing to move MHz to Hz.
Board check: Which particle can have a bremsstrahlung interaction?
Any charged particle can radiate bremsstrahlung when accelerated/decelerated in a Coulomb field. In practice, electrons and positrons matter most because radiative losses scale inversely with particle mass squared. Neutrons, photons, and neutrinos are not the classic charged-particle bremsstrahlung answer.
Decay Mode Signatures
| Mode | Signature | Board Memory |
| Beta-minus | n → p + e- + anti-ν; A same, Z increases by 1 | Neutron-rich nucleus moves up in Z. |
| Beta-plus | p → n + e+ + ν; A same, Z decreases by 1 | Needs at least 1.022 MeV for positron creation. |
| Electron capture | p + e- → n + ν; A same, Z decreases by 1 | Produces characteristic x-rays/Auger electrons from shell vacancy. |
| Alpha | A decreases by 4, Z decreases by 2 | Heavy nuclei; discrete alpha energies. |
| Gamma | No A or Z change | Nuclear de-excitation. |
| Internal conversion | No A or Z change; orbital electron ejected | Competes with gamma emission. |
Decay Diagrams Without Panic
- Vertical transition on a decay scheme = nuclear de-excitation, usually gamma or internal conversion.
- Beta spectra are continuous because energy is shared with a neutrino/antineutrino.
- Alpha and gamma emissions are discrete-energy processes in simple diagrams.
- Electron capture and internal conversion both produce atomic vacancies, so both can lead to characteristic x-rays or Auger electrons. The nuclear change is different.
- Positron annihilation produces two 0.511 MeV photons traveling nearly 180 degrees apart after the positron slows.
Activity Math
- A = λN. If you know atoms and half-life, convert half-life to seconds, compute λ, then activity in Bq.
- A(t)=A0(1/2)t/T1/2. Count half-lives when possible; it is faster and safer than logs.
- Rule of 72: approximate percent decay per unit time = 72 / T1/2 when the half-life is in that unit.
- Teff = (TphysTbio) / (Tphys + Tbio). Effective half-life is always shorter than either component.
- Total decays from a source = A0 / λ. Permanent implant total dose is proportional to initial dose rate divided by λ.
Parent-Daughter Equilibrium
| Parent vs Daughter | Name | What Happens |
| Parent half-life much longer than daughter | Secular | Daughter activity grows until it approximately equals parent activity. |
| Parent longer, but not enormously longer | Transient | Daughter rises, peaks, then appears to decay with parent; daughter can exceed parent. |
| Parent shorter than daughter | No useful equilibrium | Parent disappears before sustaining daughter. |
Exam trap: gamma emission and internal conversion compete with each other. Beta-minus and beta-plus do not "compete" in the same nucleus in the same simple way; they reflect opposite N/Z pressures.
Generator and Activation Logic
- A useful generator has a parent long enough to ship/use and a daughter short enough to grow in quickly.
- For neutron activation, add the incident particle to the target nucleus and conserve A/Z after emitted particles leave.
- Specific activity increases as half-life decreases for the same number of radioactive atoms because A = λN.
Charged Particle Logic
- Stopping power is energy loss per path length. Collision stopping makes ionization/excitation; radiative stopping makes bremsstrahlung.
- Collision stopping roughly increases with z2/v2. Doubling particle charge matters more than doubling mass.
- Bremsstrahlung yield rises with particle energy and absorber Z, and is far more important for electrons than heavy charged particles.
- LET is local energy deposition density. High LET generally means dense ionization, higher RBE, and lower OER, but clinical protons are still assigned RBE 1.1 in standard planning.
- Electron multiple scattering is why electron fields spread laterally and why small cutouts lose lateral charged particle equilibrium.
| Particle | Dominant Exam Physics | Clinical/Shielding Memory |
| Electron | Multiple Coulomb scattering, collision + radiative stopping. | Finite practical range, broad penumbra with depth, bremsstrahlung tail. |
| Proton | Collision stopping, Bragg peak, nuclear interactions. | Range uncertainty and distal edge sensitivity. |
| Alpha | High charge, high LET, short range. | Dangerous internally, stopped by very thin external shielding. |
| Neutron | Indirectly ionizing; elastic/inelastic scatter and capture. | Hydrogenous moderation, capture gammas, high radiation weighting factor. |
Photon Interaction Logic
| Interaction | Where It Matters | High-Yield Consequence |
| Coherent/Rayleigh | Low energy, high Z | No energy transfer to matter; contributes to scatter blur in imaging. |
| Photoelectric | kV range, high Z | Strong Z dependence; bone and iodine stand out. |
| Compton | Therapy MV range in soft tissue | Depends mainly on electron density, not Z. Dominant for Co-60/Gamma Knife in brain. |
| Pair production | > 1.022 MeV, rises with energy and Z | Produces positron/electron pair; annihilation photons after positron slows. |
| Photonuclear | High-energy linac photons, especially >10 MV | Neutron production concern for 15/18 MV beams. |
I = I0e-μx is narrow-beam attenuation. Broad-beam geometry adds scatter back into the detector, so apparent attenuation is less severe. HVL hardens a polyenergetic beam because low-energy photons are preferentially removed.
| Interaction | Approximate Dependence | Answer Shortcut |
| Photoelectric | Roughly Z3/E3 | Dominates kV contrast and bone dose. |
| Compton | Electron density, weak Z dependence | Dominates MV soft-tissue therapy dose. |
| Pair production | Threshold 1.022 MeV, rises with Z and energy | Relevant above threshold, more with high-energy beams/high-Z materials. |
| Photonuclear | High-energy photons interacting with nucleus | Neutrons from high-MV treatment heads. |
Board check: For a soft-tissue head target, why does Gamma Knife dose deposition mainly follow Compton physics?
Co-60 emits about 1.17 and 1.33 MeV photons, average about 1.25 MeV. In soft tissue at those energies, Compton dominates.
Neutron and Proton Logic
- Fast neutrons lose energy most efficiently in hydrogen-rich material through elastic scattering; slow neutrons are more likely captured.
- Neutron protection needs hydrogenous moderation plus capture shielding. For high-energy photon vaults, maze design and door composition matter.
- Protons have finite range and a Bragg peak. The distal edge is biologically and geometrically sensitive, so avoid placing it in a critical serial OAR when possible.
- Range uncertainty comes from CT number to stopping-power conversion, setup/anatomy changes, and motion. Robust optimization is not optional thinking in proton planning.
Kilovoltage Tube Logic
- Thermionic emission releases electrons from the cathode. Tube current controls photon quantity; kVp controls spectrum endpoint and beam quality.
- λmin = hc/eV. Maximum photon energy equals electron kinetic energy; filtration does not change that endpoint.
- Filtration removes low-energy photons, increasing HVL/effective energy and decreasing intensity.
- Anode angle increase makes the effective focal spot larger, improves field coverage, reduces heel effect severity, and worsens spatial resolution.
- The oil bath removes heat and provides electrical insulation.
- Tungsten K-characteristic x-rays need incident electrons above the K-shell binding energy; K lines are roughly 59 and 67 keV.
| Parameter Change | What Increases | What Does Not Increase |
| Increase mA | Photon fluence/output, heat | Endpoint energy, effective energy |
| Increase kVp | Endpoint energy, effective energy, output, penetration | Tube current |
| Add filtration | HVL, effective energy, mean energy | Maximum photon energy |
| Increase anode angle | Effective focal spot size, field coverage | Spatial resolution, heel effect severity |
| Decrease focal spot | Spatial resolution | Heat capacity |
Linac Head and RF Chain
| Component | Board Role | Trap |
| Magnetron | Generates microwaves directly; common in lower-energy machines. | Not an amplifier. |
| Klystron | Amplifies RF from a low-power source. | Does not generate microwaves from scratch. |
| Thyratron | High-speed switch/controlled rectifier for pulsed power. | Not the voltage step-up transformer. |
| Waveguide | Accelerates electrons with RF fields; standing or traveling wave. | Transmission waveguide carries RF to accelerator structure. |
| SF6 gas | Insulates high-voltage/RF waveguide components because of high dielectric strength. | Not a coolant and not the accelerating medium. |
| Bending magnet | Directs electrons from accelerator to target/foil; energy analyzes/focuses. | Acts on electrons, not produced photons. |
| Target | Bremsstrahlung photon production. | Removed for electron mode. |
| Flattening filter | Flattens forward-peaked photon beam at a specified depth. | Removed in FFF and electron mode. |
| Scattering foil | Broadens electron beam. | Not used in photon mode. |
| Monitor chamber | Terminates dose by MU; checks symmetry/flatness. | Still present in electron mode. |
Treatment Machine Family Tree
| Machine | What It Accelerates/Uses | Exam Hook |
| Linear accelerator | Electrons accelerated in a straight waveguide | Photon mode uses target; electron mode removes target. |
| Betatron | Electrons induced by changing magnetic flux | Can produce electrons or photons with a target; mostly historical. |
| Microtron | Electrons recirculated through RF cavity | Energy gain per pass with magnetic recirculation. |
| Cyclotron | Charged particles in spiral path, fixed magnetic field | Relativistic mass/velocity limits classic fixed-frequency design. |
| Synchrotron | Charged particles in fixed ring | Magnetic field and RF vary with particle energy. |
| Gamma Knife | Many Co-60 sources | Co-60 average photon energy about 1.25 MeV. |
| Tomotherapy | Helical fan-beam 6 MV linac | Binary MLC, no flattening filter profile. |
| CyberKnife | Robotic compact linac | Non-isocentric beams, image guidance, often cones/MLC. |
Collimation, MLC, and FFF
- Modern MLC transmission is typically 1-3%. Interleaf leakage is between leaves; intraleaf leakage is through a leaf; tongue-and-groove reduces leakage but can make a narrow underdose band.
- Dynamic MLC delivery is more sensitive to systematic leaf-position errors than static shaping. A 1 mm systematic error can matter.
- FFF removes the flattening filter: dose rate rises, head scatter falls, out-of-field dose falls, spectrum softens, and the profile is peaked rather than flat.
- FFF does not magically mean "higher energy." A nominal 6X FFF beam is often less penetrating than flattened 6X.
- Rounded MLC leaf ends make penumbra more consistent as leaves move across the divergent beam. The price is partial transmission through the rounded tip, modeled with the dosimetric leaf gap.
MLC Error Language
| Term | Meaning | Why It Is Tested |
| Dosimetric leaf gap | Modeling parameter for rounded leaf-end transmission and geometry. | Small gap errors can bias IMRT/VMAT dose. |
| Tongue-and-groove | Interlocking leaf design to reduce interleaf leakage. | Can cause narrow underdose if adjacent leaves expose a region sequentially. |
| Interleaf leakage | Leakage between adjacent leaves. | Important with high MU treatments. |
| Intraleaf transmission | Transmission through the leaf body. | Typical modern value around 1-3%. |
| Leaf positioning accuracy | Actual leaf vs planned leaf location. | Systematic errors matter more than isolated random errors. |
Quantity Decoder
| Quantity | Definition | Do Not Confuse With |
| Fluence | Particles crossing a sphere per cross-sectional area. | Planar fluence through a flat plane. |
| Energy fluence | Radiant energy per area; for monoenergetic beam = fluence x energy. | Fluence rate. |
| Kerma | Kinetic energy released per unit mass. | Dose, unless charged particle equilibrium holds. |
| Absorbed dose | Energy deposited per unit mass. | Equivalent/effective dose in Sv. |
| Exposure | Ionization in air from photons. | Not defined for electrons/protons or in tissue. |
Detector Choice
- Ion chambers are the reference workhorse: stable, near tissue equivalent after corrections, and NIST-traceable through calibration coefficients.
- Diodes are sensitive to energy, temperature, field size, dose rate history, and angle. They are not meaningfully pressure-dependent like air chambers.
- TLDs are read by heat. OSLDs are read by light. Radiochromic film is near tissue equivalent and self-developing; use net optical density.
- Modern EPIDs are usually indirect detectors: scintillator plus photodiode array, commonly amorphous silicon.
- Free-air ion chambers are standards-lab devices, not the usual meter for vault barrier surveys.
| Detector | Strength | Board Weakness / Correction |
| Farmer chamber | Reference calibration in broad fields | Volume averaging in small fields/high gradients. |
| Parallel-plate chamber | Electron dosimetry, buildup/surface region | Guard ring, polarity, and calibration details matter. |
| Diode | High sensitivity, small fields | Energy, temperature, angular, dose-rate, and field-size dependence. |
| Diamond | Near tissue equivalent, small field utility | Detector-specific correction factors still needed. |
| Film | High spatial resolution planar dose | Scanner, orientation, calibration curve, net optical density. |
| Ion chamber survey meter | Barrier photon dose-rate surveys | Use appropriate energy range and pulsed-field response. |
| GM meter | Contamination/presence checks | Poor quantitative therapy barrier meter. |
Reference Calibration
TG-51 is an absorbed-dose-to-water protocol for Co-60, MV photons, and electrons. It is not a brachytherapy source-strength protocol for Ir-192.
| Item | Photon | Electron |
| Reference field | 10 x 10 cm2 | Usually cone/applicator field with adequate size for energy |
| Reference depth | 10 cm water-equivalent depth | dref = 0.6R50 - 0.1 cm |
| Beam quality | %dd(10)x | R50 |
| Core correction | kQ | kQ plus gradient/replacement conventions |
| Corrected reading | M = MrawPTPPionPpolPelec plus local leakage/timing corrections if needed. |
| ADCL calibration cycle | Ion chamber/electrometer calibration is usually kept on a 2-year cycle; annual machine output calibration is a separate clinic QA item. |
Electron depth-ionization conversion: for I50 in cm, R50 = 1.029I50 - 0.06 for I50 <= 10 cm, and R50 = 1.059I50 - 0.37 for I50 > 10 cm. Mean incident electron energy is E0 = 2.33R50.
TG-51 Correction Factor Triggers
| Correction | Corrects For | Memory Hook |
| PTP | Temperature/pressure effect on air density | Open-to-air ion chamber reading changes with weather. |
| Pion | Ion recombination | More important for pulsed/high-dose-per-pulse beams. |
| Ppol | Polarity effect | Compare readings at opposite bias polarity. |
| Pelec | Electrometer calibration | Chamber-electrometer system factor. |
| kQ | Beam quality conversion from Co-60 calibration quality | Photon quality uses %dd(10)x; electron quality uses R50. |
Saturation curve logic: in the saturation region, collected charge should be nearly independent of bias voltage. If increasing voltage still meaningfully increases reading, recombination is not negligible. Pulsed beams need two-voltage or equivalent recombination correction discipline.
Depth-Dose and Scatter
| Factor | Meaning | Board Directionality |
| PDD | Dose at depth divided by dose at dmax for same SSD setup. | Increases with energy, SSD, and field size; decreases with depth. |
| TMR | Dose at depth divided by dose at dmax with detector points at same source distance. | Independent of SSD; used for SAD/isocentric calcs. |
| Sc | Collimator/head scatter. | Depends on collimator setting. |
| Sp | Phantom scatter. | Depends on field size at phantom/patient. |
| Scp | Total output factor. | Measured in phantom; often split into ScSp. |
| OAR | Off-axis ratio. | Profile change relative to central axis, not organ-at-risk in physics tables. |
Percent Depth Dose Directionality
| Change | PDD Effect | Why |
| Increase beam energy | Increases PDD, deeper dmax | More penetrating beam. |
| Increase field size | Increases PDD | More phantom scatter contributes dose at depth. |
| Increase SSD | Increases PDD | Inverse square difference between dmax and depth is reduced. |
| Increase depth | Decreases PDD after dmax | Attenuation and inverse square dominate. |
| Add low-density lung in path | Can reduce attenuation but perturb electron equilibrium | Simple equivalent path length can fail near interfaces. |
PDD to TMR approximation: conceptually remove the SSD inverse-square effect from PDD. A common working form is TMR(d,rd) approx PDD(d,r,SSD)/100 x [(SSD+d)/(SSD+dmax)]2 x [Sp(rdmax)/Sp(rd)]. On a board problem, the point is usually directionality: TMR is an SAD quantity and is not the same thing as PDD/100.
Monitor Unit Patterns
First branch: SSD question uses PDD. SAD/isocenter question uses TMR/TPR. If the table hands you PDD and says 100 cm SSD, do not use TMR because it feels more modern.
| Setup | Skeleton | Notes |
| SSD | MU = Rx / [O x Sc x Sp x modifiers x PDD/100 x ISF] | ISF corrects from calibration geometry to treatment point geometry. |
| SAD | MU = Rx / [O x Sc x Sp x modifiers x TMR] | Use dose per beam if fields are equally weighted. |
| Wedge pair | wedge angle = 90 - hinge angle/2 | Hinge 135 degrees -> wedge 22.5 degrees. |
| Radiologic path | ∑ density x thickness | 3 cm lung at density 0.25 behaves like 0.75 cm water-equivalent path. |
| Field gap | gap ~ d(L1/SSD1 + L2/SSD2)/2 | Half-beam block removes divergence on that side. |
Dose Perturbation and Out-of-Field Rules
| Situation | Fast Answer | Trap |
| Carbon-fiber couch in beam | Attenuates the beam; if unmodeled, delivered dose at target can be low for beams through couch. | It is a dosimetric effect, not just a collision issue. |
| Bone/high-Z interface | Can increase dose near entrance side from backscatter and perturb dose around exit side. | Direction and magnitude depend on energy, material, and geometry. |
| Metal implant | Causes CT artifact and dose perturbation; overrides/model-based algorithms help but do not remove uncertainty. | High density on CT is not automatically accurate material assignment. |
| Out-of-field near target | Mostly patient/internal scatter. | Shielding only at the head will not remove near-field patient scatter. |
| Out-of-field far from target | Head leakage and collimator scatter become relatively more important. | High-MU IMRT/VMAT can increase leakage contribution. |
Special Beam Rules
| Beam | Rules | Traps |
| Electrons | Rp ~ E/2, R90 ~ E/3.2, practical treatment depth ~ E/3. | Surface dose increases with energy. Small cutouts, obliquity, and low energy can change PDD. |
| Electron field size | Need lateral scatter equilibrium; small fields reduce output and alter depth dose. | Cutout factor is not just area. |
| Bolus | Raises surface dose and shifts depth-dose curve toward surface. | Bolus does not increase penetration. |
| Protons | Finite range, Bragg peak, SOBP, RBE convention 1.1. | Distal edge has high LET/range uncertainty; motion interplay matters in PBS. |
| TBI | Spoiler increases surface dose; lung blocks reduce lung dose. | Long SSD lowers dose rate; AP/PA may be easier for weak patients. |
| TSEI | Large SSD, multiple fields/poses, high surface dose. | Soles, scalp, perineum, and skin folds need attention. |
Electron Clinical Rules
- Approximate therapeutic range: R90 ~ E/3.2; practical range: Rp ~ E/2.
- Minimum field dimension should generally exceed practical range for stable output/depth dose.
- Obliquity increases surface dose and shifts dose proximally; it also broadens penumbra.
- Air gaps reduce output and alter effective SSD; extended SSD corrections are electron-specific, not simple photon inverse square alone.
- High-Z shielding in electron fields can make bremsstrahlung; use appropriate thickness and consider low-Z bolus/covering material near skin.
Proton Board Rules
| Concept | High-Yield Rule | Trap |
| RBE | Clinical proton plans conventionally use RBE 1.1; photons/electrons use 1.0. | Carbon ion RBE is variable and model-dependent. |
| Range | Range is dominated by proton energy and patient stopping power. A 200 MeV proton has range on the order of 26 cm in water. | HU-to-stopping-power calibration drives range uncertainty. |
| Range uncertainty | Common mental model: distal/proximal margin includes a percent of range plus setup. | Range margin is along the beam direction, not a uniform 3D shell. |
| SOBP modulation | Wider modulation adds lower-energy components and generally increases entrance dose. | There is no photon-like buildup region for protons. |
| Lateral penumbra | Aperture systems can be sharp near surface, but multiple Coulomb scattering broadens penumbra with depth. | Distal edge and lateral edge are different uncertainty problems. |
| PBS interplay | Spot scanning plus moving anatomy can create hot/cold interplay. | Repainting, gating, compression, and robust optimization are mitigation tools. |
TG-142 Linac QA Values To Know
| Cadence | Test | Tolerance |
| Daily | Photon output constancy | 3% |
| Daily/weekly | Electron output constancy | 3%; daily for machines with unique electron monitoring needs. |
| Daily | Lasers | Non-IMRT 2 mm; IMRT 1.5 mm; SRS/SBRT 1 mm. |
| Daily | ODI | 2 mm conventional/IMRT; 1 mm SRS/SBRT. |
| Monthly | Photon/electron output and backup monitor chamber | 2% |
| Monthly | Light-radiation coincidence, symmetric jaws | 2 mm or 1% per side. |
| Monthly | Dynamic MLC leaf positioning | About 1 mm; static positioning about 2 mm. |
| Annual | TG-51 output calibration | 1% from baseline/expected. |
| Annual | Flatness/symmetry baseline change | 1% |
| SRS | Overall localization/delivery accuracy | 1 mm is the board number. |
Protocol Index: What Each Report Is For
| Protocol / Report | Use | Classic Exam Association |
| TG-51 | Reference absorbed dose to water calibration | kQ, %dd(10)x, R50. |
| TG-142 | Medical accelerator QA | Daily 3%, monthly 2%, SRS tighter geometry. |
| TG-43 | Brachytherapy dose calculation formalism | Air-kerma strength, dose-rate constant, g(r), F(r,θ). |
| TG-56 | Brachytherapy QA | HDR source strength and positional checks. |
| TG-66 | CT simulator QA | Laser/imaging plane/table alignment. |
| TG-100 | Risk-based quality management | FMEA, process maps, fault trees, quality management by risk. |
| TG-101 | SBRT recommendations | Steep gradients, image guidance, normal tissue constraints. |
| TG-119 | IMRT commissioning test cases | Benchmarking planning/delivery accuracy. |
| TG-135 | Robotic radiosurgery QA | CyberKnife-style delivery systems. |
| TG-203 | Cardiac implantable electronic devices | Risk stratification by dose, pacing dependence, neutrons. |
| TG-218 | IMRT measurement-based patient-specific QA | 3%/2 mm, 95% tolerance, 90% action. |
| TG-224 | Proton machine QA | Range, spot position, output, imaging/safety checks. |
| TG-302 | Surface-guided radiotherapy | SGRT for setup, DIBH, frameless SRS, motion monitoring, and QA. |
| TG-307 | EPID-based IMRT/VMAT QA | Pre-treatment and transit dosimetry with portal imagers. |
| MPPG 11.a | Plan and chart review | Minimum prudent physics support for plan/chart review. |
Other Safety/QA Numbers
- TG-218 commonly tested universal IMRT QA gamma: 3%/2 mm, global normalization, absolute dose, 10% threshold, 95% tolerance, 90% action.
- TG-101 SBRT mindset: steep dose fall-off outside PTV is central to reducing toxicity.
- MPPG 9.a/9.b SRS/SBRT annual end-to-end dosimetric tolerance for measured vs calculated dose is commonly 5%.
- TG-203 cardiac implantable device risk: >5 Gy cumulative device dose and neutron-producing beams are high-risk flags.
- MPPG 11.a cadence language: physics chart review should occur at regular intervals, practically within each block of about 5 treatment fractions, and at clinically meaningful transitions.
- Small field definition is not simply "less than 10 x 10." Think source occlusion, loss of lateral charged particle equilibrium, and detector size relative to field.
Risk Analysis Language
| Term | Meaning | Exam Hook |
| FMEA | Prospective failure modes and effects analysis | Used before an event to identify high-risk process steps. |
| RCA | Root-cause analysis | Reactive; performed after an event or near miss. |
| Process map | Step-by-step workflow diagram | Foundation for FMEA. |
| Fault tree | Top-down analysis of paths leading to failure | Starts with undesired event. |
| Statistical process control | Control charts and process drift detection | Monitors stability over time. |
| Not FMEA's job | Deciding which workflow steps are nonessential | FMEA scores failures in a defined process; it is not just a lean-process trimming tool. |
Dose Reporting and Volumes
- GTV = visible disease. CTV = microscopic risk. ITV = motion envelope/internal uncertainty. PTV = setup and delivery uncertainty margin. PRV = OAR plus uncertainty.
- ICRU 83 shifted IMRT reporting away from a single point: use dose-volume reporting such as D98% near-min, D2% near-max, and D50% median dose.
- Conformity asks "does high dose match target?" Homogeneity asks "how even is target dose?" Gradient asks "how fast does dose fall?"
| Metric | Meaning | Fast Interpretation |
| D98% | Dose received by 98% of target | Near-minimum dose. |
| D2% | Dose received by hottest 2% of target | Near-maximum dose. |
| D50% | Median dose | Recommended central reporting metric for IMRT-style plans. |
| V20 | Volume receiving at least 20 Gy | Dose-volume threshold, common in lung. |
| D0.03cc | Small-volume maximum-like dose | Used because true point max is unstable. |
Dose Algorithms
| Algorithm | Concept | Where It Breaks |
| Pencil beam | Fast kernel along ray lines. | Lung, interfaces, small fields. |
| Convolution/superposition | Models scatter transport better. | Still approximate in extreme heterogeneity. |
| Collapsed cone / AAA | Clinical workhorse for photons. | Less exact than deterministic/Monte Carlo at interfaces. |
| Acuros / deterministic | Solves transport equation with material assignment. | Material mapping and reporting mode matter. |
| Monte Carlo | Particle transport simulation. | Statistical uncertainty and commissioning burden. |
Simulation, Motion, and Registration
- Changing CT kVp can change the HU-density calibration. mAs mainly changes noise.
- Aliasing occurs when sampling frequency is less than twice the highest spatial frequency in the object.
- MIP is useful for bright/high-density moving targets such as many lung nodules; MinIP or phase-by-phase contouring may be needed for hypodense lesions.
- MRI detects RF signal emitted by relaxing nuclei after excitation, not x-rays.
- DIBH for breast reduces heart exposure and improves reproducibility, but it requires active patient participation.
- CBCT is excellent for setup, but it is not continuous beam-on motion monitoring by itself.
- Beam hardening makes dense structures appear with streak/cupping artifacts; partial-volume averaging blurs small high-contrast structures across voxel boundaries.
4DCT Image Sets
| Image Set | Best For | Trap |
| MIP | Hyperdense/high-contrast moving targets, often lung nodules | Can miss hypodense liver/pancreas lesions. |
| MinIP | Hypodense structures/lesions when visible | Not a universal ITV tool. |
| Average CT | Dose calculation for many motion-managed plans | Blurs anatomy; not always adequate for contouring target extent. |
| Phase CT | Motion review and phase-specific contouring | One phase alone may underrepresent full motion. |
| Slow CT / free-breathing CT | Rough motion-inclusive anatomy in some settings | Less explicit than 4DCT for respiratory motion. |
Registration and Adaptive Therapy
| Concept | Meaning | Board Trap |
| Rigid registration | Translation/rotation only. | Cannot represent organ deformation or weight-loss anatomy change. |
| Deformable registration | Maps anatomy with spatially varying deformation vectors. | Useful but must be validated; it can create plausible-looking wrong anatomy. |
| Mutual information | Similarity metric often used for multimodality registration. | Does not require identical image intensity scale. |
| Online adaptive | Plan is adapted for the anatomy of the same treatment session before delivery. | Requires expedited contouring, dose calculation, QA, and approval workflow. |
| Offline adaptive | New plan is generated from accumulated interval imaging for future fractions. | Not delivered in the same session that triggered the change. |
| MR simulation / MR-linac | Excellent soft tissue; dose calculation still needs electron density assignment or synthetic CT. | MRI intensity is not HU. |
Modulation and Data Flow
- Inverse planning adjusts beamlet weights to minimize a cost function.
- Increasing fluence smoothing usually reduces modulation complexity and monitor units.
- VMAT can modulate MLC position, gantry speed, and dose rate; beam energy and radiation type are not continuously modulated during the arc.
- DICOM objects contain tags with group/element numbers, value representation, value length, and value field. DICOM-RT moves images/plans/structures, but does not directly control the linac.
- Machine log files are useful QA data, but they are not themselves standard DICOM radiotherapy objects. RTPLAN, RTSTRUCT, RTDOSE, RTIMAGE, REG, and waveform objects are the safer exam answers.
- Pre-treatment IMRT QA in a phantom checks deliverability and dose agreement in that QA geometry; it does not prove patient setup, anatomy, collision clearance, or every transfer step.
- FLASH is usually defined at ultra-high dose rates exceeding about 40 Gy/s.
Source-Strength Formalism
TG-43U1 specifies source strength by air-kerma strength rather than apparent activity. Dose-rate calculation separates source strength, dose-rate constant, geometry, radial dose function, and anisotropy.
| Term | Meaning | Board Hook |
| SK | Air-kerma strength | Unit U = cGy cm2 h-1. |
| Λ | Dose-rate constant | Converts source strength to dose rate at reference geometry. |
| G(r,θ) | Geometry factor | Inverse-square/source-length geometry. |
| g(r) | Radial dose function | Absorption and scatter along transverse plane. |
| F(r,θ) | Anisotropy | Angular variation, self-attenuation, source construction. |
TG-43 vs model-based dose calculation: TG-43 assumes water-based conditions and does not fully model patient heterogeneity, applicator shielding, or finite patient scatter. Model-based brachytherapy algorithms address those effects; the reporting trap is to specify whether dose is reported to water or medium.
Source Timing and Dose Rate
| Item | Number | Use |
| Ir-192 | 73.8 d, average energy ~0.38 MeV | HDR workhorse; treatment time increases as source decays. |
| I-125 | 59.4 d, ~28 keV | Permanent prostate/eye plaque seeds. |
| Pd-103 | 17 d, ~21 keV | Shorter half-life, higher initial dose rate for same total dose. |
| Cs-137 | 30 y, 662 keV | Historical LDR. |
| HDR definition | >12 Gy/h | ICRU dose-rate class. |
| LDR definition | 0.4-2 Gy/h | Classic low dose rate range. |
- HDR treatment time scales inversely with current source strength: tactual = tnominal x Snominal/Sactual.
- Transit dose grows with number of fractions for the same total prescription because the source travels in and out each fraction.
- Point A is classically 2 cm superior along the tandem and 2 cm lateral. The modern limitation is obvious: point-based prescription ignores patient anatomy.
- Well chambers are used for HDR source strength checks; Farmer chambers are not the source-strength tool.
- HDR source positioning accuracy is a millimeter-level issue, not a casual 3 mm issue. Full calibration language uses +/-1 mm source positioning accuracy.
IORT and Special Brachy Modalities
| Modality | Typical Technology | Board Hook |
| Electron IORT | Mobile/dedicated electron unit, often up to about 12 MeV. | Sharp practical range; shielding and applicator alignment dominate setup. |
| Low-kV IORT | Miniature x-ray source around 50 kV. | Rapid dose fall-off; high surface/contact dose. |
| HDR IORT | Ir-192 afterloader with surface applicator/flap or interstitial catheters. | Source path, transfer tubes, dwell positions, and emergency procedures matter. |
| Electronic brachytherapy | Electrically generated low-energy x-rays. | No radioactive source decay, but output/source QA still required. |
Source QA and Directive Traps
| Scenario | Know This | Exam Trap |
| HDR written directive | Includes patient/site, radionuclide, dose, fractionation, and treatment site/volume before treatment. | Patient exposure rate for release is not an HDR written directive component. |
| HDR source strength | Measured with a well-type ionization chamber and independently checked. | Not a Farmer chamber measurement. |
| HDR interlocks/emergency | Check door, radiation monitor, applicator/transfer guide tube integrity, emergency retraction, timer. | Emergency procedures are not "annual-only" in practical programs; know daily/quarterly/annual categories from TG-56-style QA. |
| Manual permanent seeds | Assay a sample or all sources per institutional/regulatory expectations; compare source strength to vendor certificate. | Air-kerma strength is the specified source strength quantity. |
| Permanent implant follow-up | Post-implant evaluation of total source strength outside the treatment site is a 60-day regulatory timing concept. | This is separate from the pre-treatment written directive. |
| Applicator diameter | For same prescription depth, larger cylinder diameter usually lowers mucosal surface dose. | Prescription depth fixed does not mean surface dose fixed. |
| Point A | Classically 2 cm superior to flange/fornix along tandem and 2 cm lateral. | Point A prescription ignores patient-specific anatomy; modern image-guided brachy uses HR-CTV/OAR DVH metrics. |
Barrier Design Logic
| Quantity | Meaning | Board Default |
| W | Workload | Dose delivered per week at 1 m or isocenter reference. |
| U | Use factor | Fraction of primary beam directed at barrier. |
| T | Occupancy factor | Fraction of time a person is in the protected area. |
| P | Design goal | Common weekly values: uncontrolled 0.02 mSv/wk, controlled 0.1 mSv/wk. |
| TVL | Tenth-value layer | n = log10(1/B) TVLs. |
- Primary barrier: B = P d2/(WUT).
- Secondary barrier includes leakage and scatter. Leakage workload can be much higher for IMRT; a common board range is C = 2-10 times primary workload.
- For a 6 MV linac, neutron shielding is not the design driver. Neutrons become a concern for high-energy photon beams above about 10 MV.
- Use an ion chamber survey meter for photon dose rate beyond a shielded barrier. GM meters are not the right quantitative choice for pulsed therapy barriers.
Shielding Question Pattern
| If This Changes... | Barrier Thickness Direction | Reason |
| Distance to occupied area increases | Decreases | Inverse square reduces required transmission. |
| Occupancy factor increases | Increases | More time in area requires more shielding. |
| Use factor toward a primary barrier increases | Increases | More beam directed at that barrier. |
| Workload increases | Increases | More dose delivered per week. |
| Area changes from controlled to uncontrolled | Increases | Lower public design goal. |
| Photon energy increases | Usually increases | Higher TVL, and neutrons above high-energy thresholds. |
Dose Limits and Regulated Events
| Limit / Requirement | Board Number |
| Adult occupational TEDE | 50 mSv/y (5 rem/y) |
| Public dose limit | 1 mSv/y (0.1 rem/y) |
| Declared pregnant worker embryo/fetus | 5 mSv for entire pregnancy, with effort toward uniform monthly exposure. |
| Individual monitoring threshold | Likely to exceed 10% of applicable limit. |
| Patient release after radioactive material | TEDE to any other individual not likely to exceed 5 mSv. |
| Survey meter calibration | Before first use, annually, and after repair affecting calibration; cannot use if indicated vs calculated exposure rate differs by more than 20%. |
| NRC medical event notification | NRC telephone notification no later than the next calendar day; written report within 15 days. |
| Medical event patient notification | Notify referring physician and patient no later than 24 h after discovery, with the regulatory physician-judgment exceptions. |
| Regulatory scope | NRC regulates byproduct/source material; state programs generally regulate linac x-ray production. |
| DOT transport index | Maximum radiation level in mrem/h at 1 m from package surface. |
- CTDIvol estimates scanner output for a standardized phantom; DLP = CTDIvol x scan length.
- Increasing mAs decreases image noise but increases dose roughly linearly.
- Increasing kVp increases penetration, changes contrast, and can alter HU-density calibration.
- Tube current modulation reduces unnecessary dose by adjusting mA to patient attenuation.
- Spatial resolution is about small objects/high spatial frequency; low-contrast resolution is about seeing subtle density differences in noise.
- MR-linac advantage: soft-tissue visualization and adaptive anatomy assessment. It is not useful because magnetic fields make oxygen molecules radiosensitizers.
| Modality / Concept | High-Yield Point | Trap |
| CT number | HU = 1000(μ - μwater)/μwater | HU-density table is protocol/energy dependent. |
| Nyquist | Sampling frequency must be at least twice the highest object spatial frequency. | Aliasing occurs when sampling is too low, not too high. |
| Window/level | Window = displayed HU range; level = center of range. | Display setting does not change underlying image data. |
| MRI signal | RF signal from precessing/relaxing nuclei after excitation. | Imaging coil detects emitted RF, not the transmitted RF itself. |
| Geometric distortion MRI | Gradient nonlinearity, B0 inhomogeneity, susceptibility, chemical shift. | Important for MR simulation and fusion. |
| PET SUV | Activity concentration normalized by injected activity/body habitus. | Uptake is not a direct radiation dose measurement. |
| PET spatial resolution | Limited by detector size, positron range, non-collinearity, depth-of-interaction, and reconstruction. | 511 keV annihilation photons are emitted nearly, but not perfectly, 180 degrees apart. |
| CT artifacts | Beam hardening, metal streaks, motion, photon starvation, partial volume. | Artifacts can corrupt HU-to-density conversion. |
| SSDE | Size-specific dose estimate adjusts CTDIvol for patient size. | Still an estimate of scanner output/dose, not patient organ dose. |
Cram Tables
Radionuclide Snapshot
| Nuclide | Half-Life | Emission / Energy | Use |
| Co-60 | 5.27 y | 1.17, 1.33 MeV gamma; avg 1.25 MeV | Teletherapy/Gamma Knife historical and current. |
| Cs-137 | 30.1 y | 662 keV gamma | Historical LDR. |
| Ir-192 | 73.8 d | Average ~0.38 MeV gamma | HDR/PDR afterloading. |
| I-125 | 59.4 d | Low-energy photons ~28 keV | Permanent seeds. |
| Pd-103 | 17 d | Low-energy photons ~21 keV | Permanent seeds, faster dose delivery. |
| Sr-90/Y-90 | 28.8 y / 64 h | Beta | Ophthalmic/surface historical; Y-90 therapy. |
| Tc-99m | 6 h | 140 keV gamma | Imaging, not therapy. |
Question-Type Map
| Cluster | What To Master | Typical Trick |
| Basics and decay | SI units, constants, decay modes, equilibrium, activity math. | Unit conversion before formula. |
| Machines | X-ray tube, filtration, Co-60, linac modes, RF, MLC, FFF. | Component that does not change when switching modes. |
| Interactions | Photoelectric/Compton/pair, stopping power, neutrons, protons. | Energy and material decide the answer. |
| Measurements | Fluence, kerma, dose, TG-51, detector behavior. | Which detector is pressure/temperature/energy dependent? |
| External beam calcs | PDD/TMR, scatter factors, equivalent square, wedges, gaps, heterogeneity. | Using the wrong table or forgetting dose per beam. |
| QA and planning | TG-142, TG-218, SRS/SBRT, ICRU 83, motion, DICOM. | Protocol number tied to a tolerance. |
| Brachy/protection | TG-43, air-kerma strength, HDR timing, shielding, NRC release/events. | Source strength vs activity; public vs release dose. |
Number Snapshot
| Category | Numbers |
| Constants | c = 3 x 108 m/s; h c = 1240 eV nm; mec2 = 0.511 MeV; 1 amu = 931.5 MeV; proton/electron mass ratio 1836. |
| Photon interactions | Pair threshold 1.022 MeV; Co-60 average 1.25 MeV; Cs-137 662 keV. |
| Decay | T1/2 = 0.693/λ; mean life 1.44 T1/2; 1 Ci = 3.7 x 1010 Bq. |
| Electrons | R50 ~ E/2.33; Rp ~ E/2; R90 ~ E/3.2. |
| Protons | Clinical RBE 1.1; 200 MeV range in water about 26 cm; range uncertainty is beam-direction/stopping-power driven. |
| Linac QA | Daily output 3%; monthly output 2%; annual calibration 1%; SRS localization mentality 1 mm. |
| IMRT/SBRT | TG-218 3%/2 mm, 95% tolerance, 90% action; SRS/SBRT annual E2E dose agreement often 5%. |
| Brachy | HDR >12 Gy/h; Ir-192 73.8 d; I-125 59.4 d; Pd-103 17 d; HDR source position +/-1 mm; Point A 2 cm up, 2 cm lateral. |
| Protection | Occupational 50 mSv/y; public 1 mSv/y; pregnancy embryo/fetus 5 mSv; patient release 5 mSv; survey meter annual/after repair. |
| Events | NRC medical event phone report by next calendar day; written report 15 d; patient notification generally 24 h after discovery with physician exceptions. |
Last-Pass Checklist
- What is the quantity? Dose, kerma, exposure, fluence, activity, equivalent dose?
- Are the units already compatible? Seconds vs days, MHz vs Hz, cm vs m, cGy vs Gy?
- What geometry is implied? SSD/PDD, SAD/TMR, inverse square, field size at collimator vs phantom?
- What energy range is implied? kV photoelectric, MV Compton, high-MV neutron, proton distal edge?
- What protocol applies? TG-51, TG-142, TG-43, TG-218, NCRP 151, NRC Part 20/35?
- Did the question ask for the exception?
Public Source Trail
Mutable protocol and regulatory details were checked against public standards and reference pages. This page is a review aid, not a substitute for the current full reports, institutional policy, or clinical physicist review.
- AAPM TG-51 / NIST citation page: TG-51 protocol; AAPM addendum: TG-51 photon addendum.
- AAPM reports: TG-142, TG-218, TG-101, TG-224, TG-43U1, TG-106.
- Additional AAPM public pages used for the second pass: TG-100, TG-119, TG-203, TG-302, TG-307, MPPG 11.a, TG-186, and AAPM Report 23.
- NRC/eCFR: 10 CFR Part 20; 10 CFR Part 35; NRC medical use FAQ for patient release under Part 35: Part 35 FAQ.
- ICRU radiation therapy report overview: ICRU radiation therapy reports.